Odesivimab

Odesivimab is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus (Ebola virus).^[1][2]

Odesivimab

Monoclonal antibody
Type	Whole antibody
Source	Human
Target	Zaire ebolavirus glycoprotein
Clinical data
Pronunciation	oh" de siv' i mab
License data	US DailyMed: Odesivimab
Drug class	Monoclonal antibody
ATC code	None
Identifiers
CAS Number	2135632-30-1
UNII	UY9LQ8P6HW
KEGG	D11921
Chemical and physical data
Formula	C6506H10024N1720O2030S42
Molar mass	146164.29 g·mol−1